Thrombogenicity Screening of Factor IX Concentrates

Thromb Haemost 1977; 38(03): 0728-0729
DOI: 10.1055/s-0038-1651891

Letters to the Editor

Schattauer GmbH

C. V Prowse

¹Blood Transfusion Service, Royal Infirmary, Edinburgh

,

D. S Pepper

¹Blood Transfusion Service, Royal Infirmary, Edinburgh

,

J. D Cash

¹Blood Transfusion Service, Royal Infirmary, Edinburgh

,

M Patterson

²Protein Fractionation Centre, Ellen’s Glen Road, Libert on, Edinburgh.

References
1 Kasper C. K. 1975; Thromboembolic complication (following the use of prothrombin complex concentrates). Thrombosis et Diathesis Haemorrhagica 33: 640.
2 Kingdon H. S, Lundblad R. L, Veltkamp J. J, Aronson D. L. 1975; Potentially thrombogenic materials in factor IX concentrates. Thrombosis et Diathesis Haemorrhagica 33: 617.
3 Middleton S. M, Bennet J. M, Smith J. K. 1973; A therapeutic concentrate of coagulation factors II, IX, and X from citrated factor VIII depleted plasma. Vox Sanguinis 24: 411.
4 Patterson M. 1977 Unpublished results.
5 Pepper D. S, Banheygl D, Howie A, Cash J. D. 1977; a In vitro thrombogenicity tests of factor IX concentrates. British Journal of Haematology 36: 555.
6 Pepper D. S, Banheygl D, Howie A. 1977 b Spectrophotometric determination of factor Xa generation in factor IX concentrates. Thrombosis and Haemostasis. in press.
7 Sas G, Owen R. E, Smith J. K, Middleton S. M, Cash J. D. 1975; In vitro spontaneous thrombin generation in human factor IX concentrates. British Journal of Haematology 31: 25.
8 White G. C, Roberts H. R, Kindgon H. S, Lundblad R. L. 1977; Prothrombin complex concentrates. Potentially thrombogenic materials and clues to the mechanism of thrombosis in vivo. Blood 49: 159.